US FDA authorizes expanded use of Abbott's Zika virus test
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
The U.S. FDA expanded its emergency use authorization of Abbott Laboratories' RealTime Zika test for the detection of the virus in whole blood samples.
Previously, the test was authorized for use with serum, plasma and urine samples.
